Nucleic Acid Turnover/Signaling
Nucleic Acid Turnover/Signaling(核酸周转/信号)
Nucleic Acid Turnover/Signaling 相关产品(69)
- GC47552Leflunomide-d4CAS: 1189987-23-2纯度: >99.00%
An internal standard for the quantification of leflunomide
- GC47933Pemetrexed-13C5 (sodium salt hydrate)纯度: >98.00%
A neuropeptide with diverse biological activities
- GC48055Riociguat-13C-d3CAS: 2749393-44-8纯度: >99.00%
A neuropeptide with diverse biological activities
- GC48116Sulfamethizole-d4CAS: 2470130-12-0纯度: >99.00%
An internal standard for the quantification of sulfamethizole
- GC48143Tenofovir-d6CAS: 1020719-94-1纯度: >99.00%
An internal standard for the quantification of tenofovir
- GC48205Trimethoprim-d3CAS: 1189923-38-3纯度: >99.00%
An internal standard for the quantification of trimethoprim
- GC48565Ofloxacin-d8 (hydrochloride)CAS: 2930288-81-4纯度: >99.00%
An internal standard for the quantification of ofloxacin
- GC48664Enoxacin-d8 (hydrochloride)CAS: 2930288-95-0纯度: >99.00%
An internal standard for the quantification of enoxacin
- GC48933Oxonic Acid-13C2,15N3 (potassium salt hydrate)纯度: >95.00%
An internal standard for the quantification of oxonic acid
- GC49101Enrofloxacin-d5CAS: 1173021-92-5纯度: >99.00%
An internal standard for the quantification of enrofloxacin
- GC49165GS-441524 tris-isobutyryl esterCAS: 2563617-99-0纯度: >98.00%
An orally bioavailable prodrug form of GS-443902
- GC49188Sarafloxacin-d8 (hydrochloride)CAS: 2733145-07-6纯度: >99.00%
An internal standard for the quantification of sarafloxacin
- GC49285Adenosine 5’-methylenediphosphate (hydrate)纯度: >98.00%
An inhibitor of ecto-5’-nucleotidase
- GC493374-AcetamidobenzenesulfonamideCAS: 121-61-9纯度: >98.00%
A metabolite of asulam and sulfanilamide
- GC494886-Methylmercaptopurine-d3CAS: 33312-93-5纯度: >99.00%
An internal standard for the quantification of 6-MMP
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC47552 | Leflunomide-d4 | 1189987-23-2 | >99.00% | |
An internal standard for the quantification of leflunomide | ||||
| GC47649 | Methotrexate (hydrate) | 133073-73-1 | >98.00% | |
A folic acid and aminopterin derivative | ||||
| GC47817 | Olaparib-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47933 | Pemetrexed-13C5 (sodium salt hydrate) | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48050 | Rifapentine-d9 | 61379-65-5 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48055 | Riociguat-13C-d3 | 2749393-44-8 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48116 | Sulfamethizole-d4 | 2470130-12-0 | >99.00% | |
An internal standard for the quantification of sulfamethizole | ||||
| GC48143 | Tenofovir-d6 | 1020719-94-1 | >99.00% | |
An internal standard for the quantification of tenofovir | ||||
| GC48205 | Trimethoprim-d3 | 1189923-38-3 | >99.00% | |
An internal standard for the quantification of trimethoprim | ||||
| GC48565 | Ofloxacin-d8 (hydrochloride) | 2930288-81-4 | >99.00% | |
An internal standard for the quantification of ofloxacin | ||||
| GC48664 | Enoxacin-d8 (hydrochloride) | 2930288-95-0 | >99.00% | |
An internal standard for the quantification of enoxacin | ||||
| GC48933 | Oxonic Acid-13C2,15N3 (potassium salt hydrate) | - | >95.00% | |
An internal standard for the quantification of oxonic acid | ||||
| GC49039 | Althiomycin | 12656-40-5 | >90.00% | |
A thiazole antibiotic | ||||
| GC49100 | Desmethyl Ofloxacin (hydrochloride) | 402930-70-5 | >98.00% | |
A metabolite of ofloxacin | ||||
| GC49101 | Enrofloxacin-d5 | 1173021-92-5 | >99.00% | |
An internal standard for the quantification of enrofloxacin | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
An orally bioavailable prodrug form of GS-443902 | ||||
| GC49188 | Sarafloxacin-d8 (hydrochloride) | 2733145-07-6 | >99.00% | |
An internal standard for the quantification of sarafloxacin | ||||
| GC49235 | 6-Methylmercaptopurine | 50-66-8 | >95.00% | |
A metabolite of 6-mercaptopurine | ||||
| GC49285 | Adenosine 5’-methylenediphosphate (hydrate) | - | >98.00% | |
An inhibitor of ecto-5’-nucleotidase | ||||
| GC49288 | Dolutegravir M1 | 1485081-26-2 | >95.00% | |
A metabolite of dolutegravir | ||||
| GC49289 | Dolutegravir O-β-D-Glucuronide | 1485692-21-4 | >95.00% | |
A metabolite of dolutegravir | ||||
| GC49337 | 4-Acetamidobenzenesulfonamide | 121-61-9 | >98.00% | |
A metabolite of asulam and sulfanilamide | ||||
| GC49347 | 8Br-HA | 2937864-01-0 | >95.00% | |
An FHIT inhibitor | ||||
| GC49488 | 6-Methylmercaptopurine-d3 | 33312-93-5 | >99.00% | |
An internal standard for the quantification of 6-MMP | ||||